Between January and August 2020, Russia imported RUB 314 bln worth of ready-made drugs (customs clearance and VAT included), which is in monetary terms (rubles) 21% lower than in 2019. This year the import dynamics are practically determined by administrative procedures associated with the launch of the labeling system, not so much by the demand situation since the launch has completely changed the usual seasonal behavior of participants in foreign economic activity for most of the mass-market drugs. These trends were much less relevant for in-bulk drugs, with the dynamics of +17.4% in monetary terms and the import volume of RUB 89.4 bln.
The online segment includes a wide variety of platforms, many of which sell beauty and health products. These are marketplaces such as www.iHerb.com and others, electronics and household appliances stores, as well as official online stores of companies, for example www.shop.philips.ru. Despite the product range overlapping with that of pharmacies, many of the online retailers still operate outside the pharmaceutical market as such and do not enter into direct competition with the pharmaceutical retail, while often influencing consumption trends, given the scale of certain players.
10/12/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 47% of Russian Doctors Report Long Wait Time for COVID-19 Results
48% of doctors say that COVID-19 test results are, on average, ready within 1-2 days, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Some even say the tests can be ready as soon as in “less than 6 hours”, which is a very promising result for mass testing. The survey did not find out any statistically significant differences between Moscow / St. Petersburg and other regions of Russia, although the situation in general is much better in the capital regions, with around 58% of the respondents choosing “maximum 1-2 days.”
10/6/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 10% of Russian Pharmacists Do Not Read Digital Media
19% of pharmacists read the digital version of the newspaper Farmatsevtichesky Vestnik, 17% – Katren-Style, and around 12% choose Novaya Apteka, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. It is noteworthy that many respondents read several publications at the same time, and the order of priority is set in approximately the same way. The top three publications include two print media, with only Katren-Style now fully digital.
10/2/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 62% of Pharmacists Ready to Give Up Print Media in Favor of Digital Editions
Only 4% of pharmacists are “definitely” not ready to read digital editions and prefer print media, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 23% of the respondents are more likely to pick the latter over the former, but are not dead set against electronic media. Speaking about the advantages of print media, the respondents most often noted the possibility to bookmark and make notes, as well as their independence from the Internet.
9/29/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 57% of Russian Doctors Say Healthcare Facilities not Ready for Rise in Coronavirus Cases
Only 11% of doctors say that healthcare facilities are fully prepared for a possible surge in the incidence of coronavirus infection, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. It is interesting that as many as 19% of the respondents from Moscow and St. Petersburg and only 8% of those coming from other regions chose this answer.
Between January and August 2020, the sales of veterinary drugs in the retail market amounted to RUB 14.3 bln (retail prices, VAT included), which is in monetary terms (rubles) hardly a hundredth of a percent higher than in 2019. The volume in physical terms is 125.1 bln minimum dosage units (MDU), which is 1.7% lower than in 2019.
Between January and June 2020, Russia exported RUB 23.2 bln worth of ready-made pharmaceutical drugs (customs duties included). This sum does not include Geropharm’s exports of insulins to Venezuela; while the company openly declares its exports, it does not reveal the volumes. The dynamics are +14.7% in monetary terms (rubles), which is significantly higher than those at the end of 2019 (+13%). The volume in physical terms exceeded 0.56 bln units, with the dynamics of +35%.
Between January and July 2020, Russia produced 267.1 bln RUB worth of pharmaceutical drugs (manufacturer’s prices, VAT included), which is in monetary terms (rubles) 19.4% higher than in 2019. In physical terms, the production volume is 2.78 bln units, with the dynamics of +13.3%. If calculated in minimum dosage units (MDU), the dynamics are +19%, with the volume of 48.8 bln MDUs.
The acute phase of the COVID-19 epidemic in Russia has more or less passed, to the point that the coronavirus realities have even begun to be safely forgotten. The virus obviously has affected the pharmaceutical market in general and the pharmaceutical retail in particular, especially since there are enough “concomitant diseases” in the industry as it is. The results of the second quarter of 2020 are negative, as expected, the consumers have to settle for the stocks made during the rush, and the macroeconomics also leaves much to be desired.